Serum-Soluble Receptor for Advanced Glycation End Products as a Potential Biomarker in Lung Cancer Patients.

J Pers Med · 2026 · PMC13028320 · PMID 41893008

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

The effect of liver inflammation and/or NAFLD on the efficacy of immune checkpoint inhibitors in LC patients is debated, although it may be significant in patients with liver metastases [ 70 , 71 ].

also in 11,015 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.